# A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia

> **NCT07293728** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Oregon Health and Science University** · enrollment: 50 (estimated)

## Conditions studied

- Hypertension
- Preeclampsia

## Interventions

- **DRUG:** Norethindrone 0.35 MG
- **DRUG:** Drospirenone

## Key facts

- **NCT ID:** NCT07293728
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07293728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07293728, "A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07293728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*